Living Cell Technologies Receives Grant from Juvenile Diabetes Research Foundation International for DIABECELL NZ Clinical Trial

US$500,000 towards current New Zealand Phase II Clinical Trial of DIABECELL

29-Apr-2010 - Living Cell Technologies Limited has received a grant of US$500,000 for its on-going Phase II clinical trial of DIABECELL® in New Zealand from the Juvenile Diabetes Research Foundation International (JDRF), a world leader in setting the agenda for diabetes research and the largest charitable ...

JDRF, Pfizer, Hadassah Medical and the Hebrew University announce collaboration

Program focuses on beta cell replication and regeneration

22-Mar-2010 - The Juvenile Diabetes Research Foundation said that it will begin a diabetes research collaboration with Pfizer, Hadassah Medical Organization, and The Hebrew University of Jerusalem on drugs to replicate and regenerate insulin-producing cells in people with type 1 diabetes. The program, under ...

DeveloGen AG receives US$ 500.000 Funding from the Juvenile Diabetes Research Foundation for Beta Cell Research

25-Feb-2010 - DeveloGen AG announced that it will receive US$ 500,000 from the Juvenile Diabetes Research Foundation, New York, USA (JDRF). The funds are dedicated to aide in the research of mechanisms for the protection of beta cells. In this two year project titled "Development of Novel Therapeutic Agents ...

JDRF To Collaborate with MediGene to Develop an Antigen-Specific Immunotherapeutic for Type I Diabetes

05-Apr-2007 - MediGene AG through its wholly owned UK subsidiary in Oxford (formerly Avidex) announced a funded collaborative research program with the Juvenile Diabetes Research Foundation (JDRF). Through its Industry Discovery and Development Partnership Program, JDRF is providing financial support for the ...